Association of the extent of therapy with prostate cancer in those receiving testosterone therapy in a US commercial insurance claims database
David S. López, Trudy Millard Krause, Jacques Baillargeon(The University of Texas Medical Branch at Galveston), Yong‐Fang Kuo(John Sealy Hospital), Randall J. Urban(The University of Texas Medical Branch at Galveston), Albert J. Farias(Keck Hospital of USC), Stephen B. Williams(Cedars-Sinai Medical Center), Danmeng Huang(The University of Texas Medical Branch at Galveston), Konstantinos K. Tsilidis(University of Ioannina), Orestis A. Panagiotou(Brown University), Mohit Khera(Texas Medical Center)
Cited by 12
Related Papers
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Risk of Fracture after Androgen Deprivation for Prostate Cancer
|New England Journal of Medicine|2005|1.4k
Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus
|Journal of the American College of Cardiology|1996|1k
Acute Hyperglycemia Attenuates Endothelium-Dependent Vasodilation in Humans In Vivo
|Circulation|1998|804
Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis
|Nature Communications|2020|694